Page results
-
This booklet is designed for teenagers and young people. It explains what you can expect when you finish your treatment for Hodgkin lymphoma.
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
Information on safer eating during treatment, for patients with blood cancer.
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
Health and wellbeing information for people affected by cancer.
-
Health and wellbeing information for people affected by cancer.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
This page has been written to tell you more about an outpatient hysteroscopy, why it is being done and what it involves.
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
File results
-
FOI/2024/0076 - Patient Portal contract and supplier
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0079 - Water procurement
-
FOI/2024/0080 - Patient treatment for botched non-surgical procedures
-
FOI/2024/0094 - Record Freedom of Information data 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0096 - Waiting lists for gynaecology treatment 2021-2024
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract